Atlas Trials

Development and Validation of a Post-operative Risk Of Local Recurrence Model Integrating Serology and Evalution (PROMISE) in Local Advanced Rectal Cancer Receiving Neoadjuvant Therapy: a Multicenter Study

Clinical trial NCT07351708 · COMPLETED

Trial details

NCT number
NCT07351708
Sponsor
Cai Zerong
Status
COMPLETED
Study type
OBSERVATIONAL
Locally Advanced Rectal Cancer (LARC)
Start date
2010-01-06
Primary completion
2022-12-30
Enrollment
2315

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.